Stockreport

Galecto Announces Reverse Stock Split

Galecto, Inc.  (GLTO) 
PDF BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cance [Read more]